Catalyst Pharmaceuticals Stock Discussion

$Catalyst Pharmaceuticals (CPRX.US)$
Breakthrough: First-Ever DMD Treatment AGAMREE Fast-Tracked in Canada

$Catalyst Pharmaceuticals (CPRX.US)$
First DMD Treatment Could Reach Canada as AGAMREE Receives Priority Review Status

$Catalyst Pharmaceuticals (CPRX.US)$ 📒

$Catalyst Pharmaceuticals (CPRX.US)$ $Teva Pharmaceutical Industries (TEVA.US)$
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals
Catalyst Pharmaceuticals (CPRX) and its licensor SERB S.A. have reached a settlement agreement with Teva Pharmaceuticals regarding patent litigation over FIRDAPSE® (amifampridine). The litigation was initiated after Teva filed an Abbreviated New Drug Application seeking to market a generic version o...

$Catalyst Pharmaceuticals (CPRX.US)$ $Teva Pharmaceutical Industries (TEVA.US)$ Reuters
1 min ago
Catalyst Pharmaceuticals Announces Settlement of Firdapse® (Amifampridine) Patent Litigation With Teva Pharmaceuticals

$KinderCare Learning Companies (KLC.US)$
$Catalyst Pharmaceuticals (CPRX.US)$
eyooooooo

$Catalyst Pharmaceuticals (CPRX.US)$ Catalyst Pharmaceuticals Enters Exclusive License, Supply And Commercialization Agreement Granting Kye Pharmaceuticals Canadian Rights To AGAMREE For Duchenne Muscular Dystrophy